Richardson D J, Smith G P, Meade T W, Langley P, Peters T J
Clin Chim Acta. 1982 May 6;121(1):87-94. doi: 10.1016/0009-8981(82)90214-5.
A rapid radioassay was used to characterise the adenosine diphosphatase (ADPase) activities in human plasma. There was a major peak at pH 9.3, 80% of whose activity was attributable to non-specific alkaline phosphatase, with the remaining 20% probably due to a specific ADPase. There was also a small peak of ADPase activity at pH 4.0. Inhibitor and chromatographic studies showed that whilst much of this activity was attributable to non-specific acid phosphatase, there was a discrete acid ADPase. Assays of plasma ADPase activities in vascular disorders, including myocardial infarction, peripheral vascular disease and diabetes mellitus, reveal no alterations from control values. Activities of alkaline ADPase were elevated in both chronic and acute liver failure. Acid ADPase was also increased in chronic liver disease and it is suggested that alterations in ADPase activities in liver disorders may contribute to the haemostatic problems observed in these patients.
采用快速放射分析法对人血浆中的腺苷二磷酸酶(ADPase)活性进行表征。在pH 9.3处有一个主峰,其活性的80%归因于非特异性碱性磷酸酶,其余20%可能归因于特异性ADPase。在pH 4.0处也有一个ADPase活性的小峰。抑制剂和色谱研究表明,虽然这种活性大部分归因于非特异性酸性磷酸酶,但存在一种离散的酸性ADPase。对包括心肌梗死、外周血管疾病和糖尿病在内的血管疾病患者的血浆ADPase活性进行检测,结果显示与对照值无差异。慢性和急性肝衰竭患者的碱性ADPase活性均升高。慢性肝病患者的酸性ADPase也升高,提示肝脏疾病中ADPase活性的改变可能导致这些患者出现止血问题。